Comprehensive Regulatory Framework at Taj Pharmaceuticals

At Taj Pharmaceuticals, Regulatory Affairs (RA) is not just a compliance division—it is the cornerstone of our global pharmaceutical operations. Our RA division is driven by a team of skilled professionals who ensure seamless navigation through the ever-evolving regulatory landscape across regulated and semi-regulated markets. With a global presence, we remain consistently aligned with international health authority requirements including USFDA, EMA (EU), MHRA (UK), TGA (Australia), ANVISA (Brazil), WHO-GMP, and many others.

Our regulatory ecosystem is tailored to support the full product lifecycle, from development and submission to post-approval maintenance, making us a reliable partner for regulatory solutions worldwide.

Global Regulatory Compliance: Expertise Across Continents

We maintain deep regulatory insight into the varying demands of global agencies:

  • North America: USFDA compliance, Drug Master Files (DMFs), ANDAs.
  • Europe: EMA centralized procedures, mutual recognition procedures (MRP), and decentralized procedures (DCP).
  • Latin America: ANVISA registrations, COFEPRIS filings.
  • Asia & Africa: TGA, SFDA, MCC, CDSCO, and GCC regulatory systems.

We conduct continuous surveillance of regulatory updates and promptly adapt internal systems, documentation, and dossier templates to reflect changes in legislation or guidance, enabling our clients to stay ahead in compliance.

Dossier Preparation and Submission Excellence

Taj Pharma has built extensive capabilities in preparing and submitting high-quality Common Technical Document (CTD), electronic CTD (eCTD), ASEAN CTD (ACTD), and country-specific dossiers. Our submissions include:

  • Module 1: Region-specific administrative information.
  • Module 2: Summaries of quality, nonclinical, and clinical data.
  • Module 3: Comprehensive quality documentation, including specifications, manufacturing processes, and validation.
  • Module 4: Nonclinical study reports.
  • Module 5: Clinical study reports.

We handle new drug applications, generic drug registrations, and post-approval variations with precision and compliance-driven strategies.

Strategic Regulatory Planning and Fast-Track Product Registration

Our RA professionals are involved from the product development stage to formulate a regulatory roadmap that minimizes delays and maximizes the probability of first-cycle approvals. We maintain direct communication with health authorities to resolve queries and expedite registration processes.

Our approach includes:

  • Gap analysis of existing data and studies.
  • Selection of optimal filing strategy (national, regional, or global).
  • Pre-submission meetings with authorities for alignment.

Labeling and Artwork Regulatory Compliance

Taj Pharmaceuticals ensures 100% regulatory conformity in all packaging and labeling materials. Our RA team develops and verifies:

  • Summary of Product Characteristics (SmPCs)
  • Patient Information Leaflets (PILs)
  • Labels and cartons

We support multilingual artwork development and region-specific adaptations for global markets, with an inbuilt labeling tracking system to ensure version control and audit readiness.

Readiness for Regulatory Audits and Inspections

Taj Pharma demonstrates exemplary audit readiness by maintaining all documents in a validated and inspection-ready state. We support audits from agencies like:

  • USFDA
  • EMA
  • WHO-GMP
  • PIC/S

We ensure swift and precise responses to regulatory queries, deficiency letters, and manage the implementation of Corrective and Preventive Actions (CAPAs) through structured internal review processes.

Advanced Electronic Submission Infrastructure

We are equipped with the latest regulatory publishing and document management systems, enabling us to prepare submissions in:

  • eCTD (Electronic Common Technical Document)
  • NeeS (Non-eCTD electronic submission)
  • Hybrid formats for emerging markets

Our digital submission workflows ensure faster review cycles, minimal manual intervention, and seamless lifecycle management of regulatory applications.

Liaison with Clients and Health Authorities Worldwide

Our Regulatory Affairs department offers dedicated support to clients across regions including MENA, CIS, ASEAN, LATAM, and Africa. We provide:

  • Complete registration documentation
  • LOAs, COPPs, FSCs, DMFs, MSDS
  • Product-specific QOS and PIFs for cosmetics

Our experienced team acts as a communication bridge between clients and regulatory bodies, ensuring transparency, responsiveness, and alignment with registration timelines.


Taj Pharma’s Oral Solid Dosage and External Preparation Manufacturing Units

Oral Solid Dosage (OSD) Facility: Innovation Meets Compliance

Taj Pharmaceuticals’ OSD facility is a modern manufacturing hub compliant with WHO-GMP, EU-GMP, and PIC/S standards. It produces a wide array of oral dosage forms such as:

  • Tablets: Plain, coated, chewable, dispersible, and effervescent.
  • Capsules: Hard gelatin and soft gel formats.
  • Pellets and Granules: Sachets, bulk, and blister-packed units.

Facility Infrastructure and Capabilities

  • Segregated cleanroom areas for granulation, compression, coating, and packaging.
  • Validated AHUs, pressure differentials, and HEPA filters for contamination control.
  • Flexible batch sizes from pilot to large-scale commercial production.
  • Dedicated lines for hormonal and non-hormonal drugs.

In-House Quality Control and Assurance

A fully operational QC lab within the plant is equipped with:

  • HPLC, FTIR, UV-VIS Spectrophotometers
  • Dissolution and disintegration apparatus
  • Microbial limit testing setups

Our stability chambers conform to ICH guidelines (Zone I-IV), and our documentation follows a stringent trail via BMRs, BPRs, SOPs, and change control records, ensuring compliance and traceability.

Packaging Versatility and Traceability

Our OSD unit offers multiple packing options:

  • Blister, strip, Alu-Alu, bottle, and sachet packing
  • Serialization and track & trace systems
  • Customizable export-oriented packaging solutions in various languages

External Preparations Plant: Dermatological and Topical Excellence

Taj Pharmaceuticals’ topical manufacturing plant is specialized in the production of creams, ointments, gels, lotions, medicated shampoos, and antiseptic liquids. It caters to Rx, OTC, and cosmeceutical markets worldwide.

Facility Design and Equipment

  • Dedicated processing zones for emulsions, semi-solids, and aqueous liquids.
  • Equipment includes planetary mixers, homogenizers, automatic tube filling, bottle sealing machines.
  • Custom pack sizes with private label manufacturing options available.

Microbial Quality and Environmental Control

  • Regular environmental monitoring and microbial limit testing
  • HVAC systems designed for cleanroom maintenance
  • Adherence to USP, EP, and BP microbial testing protocols

Why Taj Pharmaceuticals is a Global Regulatory Leader

  • Regulatory Depth: Unmatched proficiency across over 80 countries.
  • Manufacturing Strength: World-class facilities with multi-product approvals.
  • Customer Support: Start-to-finish assistance—from dossier filing to post-marketing surveillance.
  • Portfolio Diversity: Over 1,500 formulations across oncology, cardiology, neurology, dermatology, and general therapeutics.
  • Compliance Culture: Deep integration of GxP principles, quality risk management, and continuous improvement.